Barrow, Hanley, Mewhinney & Strauss’s Amneal Pharmaceuticals AMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,576
Closed -$9.55K 302
2024
Q1
$9.55K Hold
1,576
﹤0.01% 209
2023
Q4
$9.57K Sell
1,576
-263
-14% -$1.17K ﹤0.01% 196
2023
Q3
$7.76K Sell
1,839
-156
-8% -$582 ﹤0.01% 204
2023
Q2
$6.18K Sell
1,995
-297
-13% -$633 ﹤0.01% 211
2023
Q1
$3.19K Hold
2,292
﹤0.01% 243
2022
Q4
$4.56K Buy
2,292
+1,058
+86% +$2.37K ﹤0.01% 223
2022
Q3
$2K Hold
1,234
﹤0.01% 248
2022
Q2
$4K Hold
1,234
﹤0.01% 225
2022
Q1
$5K Sell
1,234
-12,463
-91% -$55.2K ﹤0.01% 232
2021
Q4
$66K Hold
13,697
﹤0.01% 230
2021
Q3
$73K Hold
13,697
﹤0.01% 228
2021
Q2
$70K Sell
13,697
-6,856
-33% -$39K ﹤0.01% 239
2021
Q1
$138K Buy
20,553
+1,318
+7% +$7.3K ﹤0.01% 210
2020
Q4
$88K Sell
19,235
-2,549
-12% -$11.3K ﹤0.01% 234
2020
Q3
$84K Buy
+21,784
New +$93.2K ﹤0.01% 273
2020
Q2
Sell
-111,896
Closed -$390K 317
2020
Q1
$390K Buy
+111,896
New +$474K ﹤0.01% 236

Other funds holding AMRX